Cosmetic formula ownership is the least-read clause in most manufacturing agreements and the most expensive one to get wrong, because it decides whether a brand can switch factories, extend its best-selling line, or survive due diligence in a sale. Most founders discover this late — usually at the exact moment the formula matters most.
What makes formulas different from trademarks is that no office keeps a register of formula ownership. A formula is typically protected as a trade secret — a right that exists only through contracts and secrecy practice, not registration. This article maps how cosmetic formula ownership works by default across OEM, ODM, and white label arrangements, what the contract can change, and which clauses to check before signing. It describes common industry practice, not legal advice; the specifics belong with a qualified lawyer in the relevant jurisdiction.
já. The Default Rules When No One Negotiates
Patents rarely fit cosmetic formulas: a patent requires publishing an enabling disclosure and expires after a set term, which is a poor trade for a cream that competitors could then copy freely. So the industry runs on trade secret law. V EU, Directive (EU) 2016/943 harmonized the definition: information that is secret, has commercial value because it is secret, and is protected by reasonable steps. Ve Spojených státech, USPTO's trade secret policy outlines the same three-part test, backed since 2016 by a federal civil cause of action under the Defend Trade Secrets Act.
The practical consequence of a registry-free right is blunt: whoever holds the master formula file, the raw material specifications, and the batch records — and keeps them secret — controls the formula by default. In a contract manufacturing relationship, that party is the factory. Payment history does not change this. A development fee buys development work; it does not transfer intellectual property unless the contract says so.
Where a project starts determines who holds what when the agreement is silent:
| Starting point | Default position | What the brand actually holds | Main risk |
|---|---|---|---|
| OEM custom development — factory formulates to the brand's brief | Developer keeps control unless ownership is assigned in writing | The right to buy finished goods; the brand name and artwork | Assuming "we paid, so we own it" |
| ODM or catalog formula — brand selects from the factory's library | Factory intellectual property, without exception | A license to sell product made from it, under the brand's mark | Believing the base is unique to the brand |
| Brand-supplied formula — brand brings its own developed formula | Brand owns its background formula | The formula it arrived with | Factory-made process improvements accruing to the factory |
Notice that in two of the three scenarios, the default answer favors the manufacturer. That is not sharp practice — it is how a possession-based right behaves when nobody negotiates.
II. Three Ownership Arrangements a Contract Can Create
Contracts can rearrange the defaults in three broad ways, each with its own price logic:
| Arrangement | What the brand gets | Cost logic | Watch for |
|---|---|---|---|
| Manufacturer retains, brand gets exclusivity | A protected market window — by category, territory, or time — while the factory keeps the formula | Lowest upfront cost; often conditioned on minimum annual volumes | Exclusivity that quietly expires with the supply agreement |
| Assignment, or buyout | Full ownership, transferred in writing | Development fee plus a separately priced buyout | An assignment with no documentation handover attached |
| Joint ownership | Shared rights on paper | Sounds like a compromise, prices like one | Deadlock over who may license derivatives to whom |
Exclusivity is not ownership. An exclusivity clause protects the market while the relationship lasts; ownership survives the relationship. Conflating the two is the single most common misunderstanding in formula negotiations, and it usually surfaces only when a brand tries to leave.
The price logic deserves one more sentence. A factory that develops "for free" has not donated the work — it has amortized the formula into the unit price and kept the intellectual property. Published founder guides and lab price lists put custom development fees anywhere from the low thousands of dollars into five figures for complex briefs, with buyouts and IP assignment often billed as a separate line. Brands pay for development either way; the negotiation is about what they hold when the invoices stop.
III. What Ownership Actually Buys
Cosmetic formula ownership is best understood as a bundle of three freedoms rather than a certificate in a drawer.
The first is portability. An owned formula, delivered with complete documentation, can be produced by a second source or moved when reformulating or improving an existing product line makes a change of factory sensible. An unowned formula makes every switching conversation start from zero — the next manufacturer must reverse-engineer or redevelop, and the product the customers know is never exactly reproduced.
The second is exit value. Acquirers run intellectual property schedules in due diligence, and a hero product whose formula belongs to a supplier reads as risk: a discount at best, a renegotiation with the factory at worst. The Seed Beauty litigation showed the mechanism in public — a manufacturer's rights reaching into a nine-figure brand transaction.
The third is extension freedom. Ownership of a base, including rights to derivatives, lets a brand spin one hero formula into a line — a fragrance-free version, a higher-active version, a body format — without renegotiating each time. For brands built around one signature texture, this freedom is usually worth more than the buyout costs.
IV. What You Can Own in ODM and White Label
The catalog model that makes ODM cosmetics fast and affordable is the same thing that rules out formula ownership: a stock base is shared infrastructure, developed once and offered to many clients, which is precisely why it carries lower minimums and shorter lead times. Asking to own a catalog formula is asking the factory to sell the road it built for everyone.
What a brand can genuinely own in this model is everything layered on top: the trademark, the trade dress, the artwork and claims copy, and — if negotiated — the specific customizations that make its version distinct. One insider nuance applies to scent: a custom fragrance compound usually remains the intellectual property of the fragrance house, not the brand and not even the cosmetics factory, so even a "signature scent" is typically held as a supply arrangement rather than an owned asset.
There is also a workable middle path. Brands that start on a stock base and later invest in moving from stock formulas to custom formulations can negotiate ownership, or at least exclusivity, on the custom variant — the delta they paid to create — while the underlying base stays with the factory. Scoped correctly, that captures most of the commercial value of ownership at a fraction of the cost.
PROTI. The Clause Checklist Before You Sign
Cosmetic formula ownership is settled in a handful of clauses, most of them short. Before signing, check:
- Background versus foreground IP — what each party brings is defined, and what the project creates is expressly allocated rather than left silent.
- Assignment versus license wording — "assigns all right, title, and interest" transfers ownership; "grants a license" ne, whatever the sales deck implied.
- Documentation deliverables — the full quantitative formula, raw material specifications with suppliers, and manufacturing process parameters are listed as handover items, not assumed.
- Exclusivity scope — category, territory, duration, and any minimum-volume conditions are stated, with survival terms if the supply agreement ends.
- Improvements and derivatives — who owns reformulations, cost-optimized versions, and line extensions developed during the relationship.
- Termination and transition — handover obligations and a transition supply period, so leaving is a process rather than a hostage negotiation.
- Confidentiality in both directions — the brand's brief, sales data, and launch plans are trade secrets too, as the Seed Beauty cases made vivid.
The timing matters as much as the wording. Ask the ownership question at quotation stage, not signing stage: two quotes that look identical per unit are not identical if one includes an assignment path and the other locks the formula to the factory. The answer re-prices the comparison.
Často kladené otázky
If a brand pays for custom development, does it own the formula?
Not automatically. In most jurisdictions, a development fee buys the development work, not the intellectual property in its output — and because formulas are protected as trade secrets rather than registered rights, the party that holds the documentation and keeps it secret controls it by default. Ownership moves when a contract says it moves, in writing, with assignment language rather than license language.
Can a manufacturer offer "vaše" formula to another brand?
If the manufacturer owns the formula and no exclusivity clause restricts it, then in most markets it may legally offer the same or a near-identical base to other clients. That is not misconduct; it is the economics of the catalog model. The protection a brand can negotiate is a scoped exclusivity clause — by product category, territory, and time, sometimes conditioned on minimum purchase volumes.
What should a formula handover actually include?
A percentage breakdown alone will not reproduce a product. A usable handover includes the full quantitative formula, raw material specifications with supplier names and grades, the manufacturing process parameters — order of addition, temperatures, mixing speeds and times — and the stability and compatibility test history. Brands buying out a formula should write these deliverables into the assignment itself, not request them afterward.
Is a formula buyout worth the cost?
It depends on the product's job. A hero product that carries the brand's reputation, features in an exit plan, or needs a second manufacturing source is worth owning outright. A trend product with an eighteen-month life usually is not. Published founder guides and lab price lists put custom development fees anywhere from the low thousands of dollars into five figures, with buyouts and IP assignment often billed separately — so treat ownership as an investment case, not a default setting.
Závěr a další kroky
Formula ownership is a purchasing decision, not a legal afterthought. The defaults favor whoever holds the documentation; the contract is the only instrument that changes them; and the cheapest moment to negotiate is before the first purchase order, when both sides still want the deal. Brands that settle cosmetic formula ownership at quotation stage never have to litigate it at exit.
Where the manufacturer stands on this question is itself a selection signal. Ausmetika, which has manufactured for global brands for more than 28 years from ISO 22716 (GMPC) certifikovaný, Sedex-audited facilities in Guangzhou, states its position publicly: clients retain all trademarks and intellectual property rights in their designs and products, and its OEM development model lists exclusive formula ownership among its stated benefits. That is the kind of position worth confirming in writing with any manufacturing partner — clarity on paper protects both sides.
If a product line is heading toward custom development, raise ownership in the first conversation. Explore Ausmetics' Výroba OEM a ODM kosmetiky služby, nebo kontaktujte Ausmetics to discuss development terms, exkluzivitu, and buyout paths before the brief goes out.